Control Bionics Limited (ASX:CBL)


right-arrow Created with Sketch. 0.025 (4.95%)
MCAP $44.27M
Last trade 12.06pm 03/12/2021 20mins delayed

Latest Announcements

24/11/2021 Price SensitivePSCBLControl Bionics Limited
18/11/2021CBLControl Bionics Limited
10/11/2021CBLControl Bionics Limited
04/11/2021CBLControl Bionics Limited
01/11/2021CBLControl Bionics Limited
29/10/2021CBLControl Bionics Limited
27/10/2021 Price SensitivePSCBLControl Bionics Limited
22/10/2021CBLControl Bionics Limited

Company Overview

Control Bionics Limited is a technology company. The Company is principally engaged in development, commercialization and sale of assistive communications technology systems namely NeuroNode within the disability sector. The Group’s core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment and external control of other devices. Its NeuroNode Trilogy system combines its NeuroNode with eye-gaze technology to create a communication system. Its NeuroNode3 combines the NeuroNode wearable device with operating systems and is suitable for users with severe impairment. Its geographical locations consist of Australia, which is engaged in sales of Trilogy units and components in Australia, and North America, which is engaged in manufacturing and sales of Trilogy units and components in North America.

Search Previous Announcements